---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-151192"
form_type: "8-K"
ticker: "RIGL"
cik: "0001034842"
company_name: "RIGEL PHARMACEUTICALS INC"
filed_at: "2021-12-17T23:59:59+00:00"
generated_at: "2026-06-27T23:58:37.790591+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Rigel Pharmaceuticals appoints Kamil Ali-Jackson to board, expanding board to 10 members

## Summary
- Board size increased from 9 to 10; Ali-Jackson appointed effective Dec. 16, 2021, term expires at 2022 annual meeting.
- Standard non-employee director compensation: $50k annual retainer, initial option grant for 120,000 shares vesting over 3 years.
- Ali-Jackson determined independent under SEC and Nasdaq rules; no transactions requiring disclosure under Item 404(a).
- Not appointed to any standing board committee at this time.

## SEC filing metadata
- accession: 0001104659-21-151192
- form_type: 8-K
- ticker: RIGL
- cik: 0001034842
- company_name: RIGEL PHARMACEUTICALS INC
- filed_at: 2021-12-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1034842/000110465921151192/0001104659-21-151192-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1034842/000110465921151192/tm2135755d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-151192
- JSON: https://secwatch.observer/filing/0001104659-21-151192.json
- Plain text: https://secwatch.observer/filing/0001104659-21-151192.txt

## Key facts
- Executive change
  Kamil Ali-Jackson was appointed as Director at RIGEL PHARMACEUTICALS INC.
  - Action: appointed
  - Role: Director
  source text: On the Effective Date, the Board appointed, upon the recommendation of the Board’s Corporate Governance, Health Care Compliance Oversight and Nominating Committee, Kamil Ali-Jackson to fill in the vacancy on the Board and to serve as a member of the Board until her successor is elected and has qualified, or sooner in the event of her death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1034842/000110465921151192/0001104659-21-151192-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.